CYBN - CONSENSUS CO - Cybin Inc.

Cybin Inc. (CYBN) relies on its own centers in North America, where innovative formulas for the therapy of mental disorders are developed. This market valuation chart for the company reflects a current figure of . Growth prospects are based on modified psilocybin for the rapid treatment of depression, which will provide pricing power in the future subject to successful regulatory approvals.

Cybin Inc. (CYBN) development of innovative psychedelic drugs using AI creates high volatility in expectations, which is smoothed by the consensus benchmark of market experts on GURU.Markets. This indicator measures the fundamental spread between the current price and the average target value, allowing the investor to assess the discount size to ensure a margin of safety and minimize the risks of capital drawdown during a market correction.